Agents and methods for detecting human adenoviruses
CA 2511248 A1 · Owner: Medizinische Hochschule Hannover · Inventors: Heim, Albert, Roland; Pring-Akerblom, Patricia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to labeled or unlabeled nucleic acids for specifically binding to DNA of human adenoviruses (HAdV-DNA) whereby the nucleic acid: a) , comprises the sequence SEQ ID NO. 1 SEQ ID NO. 2 or SEQ ID NO. 3; b) , comprises a sequence having a homology of greater than 78 % to SEQ ID NO. 1 SEQ ID NO. 2 or SEQ ID NO. 3 or; is complementary to a nucleic acid according to a) or b). The invention also relates to methods for detecting HAdV-DNA.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 14, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 14, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 14, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.